Based on GBD 2021 data, this article systematically analyzes the changes in the disease burden of liver fibrosis/chronic liver disease, benign gallbladder/biliary tract diseases, and pancreatitis in the Chinese population aged 15-39 from 1990 to 2021. The results show that in 2021, the number of new cases exceeded 10.44 million, a 3.8% increase from 1990; however, the number of patients, deaths, and DALYs decreased by 20.4%, 59.6%, and 50.2%, respectively, indicating improved diagnosis and treatment. Among the three diseases, the age-standardized incidence rate (ASIR) of liver and biliary tract diseases significantly increased (EAPC=0.43 and 1.07), and the prevalence rate (ASPR) of biliary tract diseases also continued to rise; while mortality decreased overall. Predictions show that the incidence of biliary tract diseases will decline from 2022 to 2030, while pancreatitis may rise.